76 related articles for article (PubMed ID: 7491346)
1. ["Prognostic markers" in serum of active and passive intravenous drug users infected with human immunodeficiency virus (HIV)].
Rogowska-Szadkowska D; Borzuchowska A; Prokopowicz D; Chodynicka B; Rogowski F; Kramarz P
Pol Arch Med Wewn; 1995 Jun; 93(6):469-74. PubMed ID: 7491346
[TBL] [Abstract][Full Text] [Related]
2. [Levels of neopterin in serum of narcotics abusers infected with human immunodeficiency virus (HIV)].
Rogowska-Szadkowska D; Borzuchowska A; Prokopowicz D; Grzeszczuk A; Chodynicka B; Rogowski F; Kramarz P
Pol Arch Med Wewn; 1994 May; 91(5):363-6. PubMed ID: 8084813
[TBL] [Abstract][Full Text] [Related]
3. Immune serum markers and CD4 cell counts in HIV-infected intravenous drug users.
Chaisson RE; Taylor E; Margolick JB; Muñoz A; Solomon L; Cohn S; Nelson KE; Vlahov D
J Acquir Immune Defic Syndr (1988); 1992; 5(5):456-60. PubMed ID: 1348535
[TBL] [Abstract][Full Text] [Related]
4. Serum B2-microglobulin and human immunodeficiency virus infection in intravenous drug users: a cross-sectional study.
De Mercato R; Rezza G; Giuliani M; Perna E; Iovinella V; Bassi A; Tagliaferro R
Boll Ist Sieroter Milan; 1990 Jun; 69(2):447-8. PubMed ID: 2152304
[TBL] [Abstract][Full Text] [Related]
5. Elevated serum levels of neopterin but not beta 2-microglobulin in HIV-1-seronegative injecting drug users.
Strickler HD; Blanchard JF; Vlahov D; Taylor E; Muñoz A; Nelson KE; Margolick JB
AIDS; 1993 Mar; 7(3):361-7. PubMed ID: 8471199
[TBL] [Abstract][Full Text] [Related]
6. Serum beta 2-microglobulin in intravenous drug users and its correlation with human immunodeficiency virus infection.
Chironna M; Fanelli M; Potenza D; Serio G; Quarto M
Int J Clin Lab Res; 1994; 24(2):90-3. PubMed ID: 7919434
[TBL] [Abstract][Full Text] [Related]
7. Serum neopterin level predicts HIV-related mortality but not progression to AIDS or development of neurological disease in gay men and parenteral drug users.
Sacktor N; Liu X; Popescu M; Marder K; Stern Y; Mayeux R
Arch Neurol; 1995 Jul; 52(7):676-9. PubMed ID: 7619023
[TBL] [Abstract][Full Text] [Related]
8. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1.
Fahey JL; Taylor JM; Detels R; Hofmann B; Melmed R; Nishanian P; Giorgi JV
N Engl J Med; 1990 Jan; 322(3):166-72. PubMed ID: 1967191
[TBL] [Abstract][Full Text] [Related]
9. The prognostic value of cellular and serologic markers in infection with human immunodeficiency virus type 1.
Dis Markers; 1990; 8(3):164-5. PubMed ID: 2125538
[No Abstract] [Full Text] [Related]
10. Markers for disease progression in intravenous drug users infected with HIV-1.
Zangerle R; Fuchs D; Reibnegger G; Fritsch P; Wachter H
AIDS; 1991 Aug; 5(8):985-91. PubMed ID: 1685652
[TBL] [Abstract][Full Text] [Related]
11. Close relationships between neopterin and beta-2-microglobulin levels in intravenous drug abusers.
Lin RY; Nygren E; Valinsky J; Lorenzana FG; Ralph H
Int Arch Allergy Appl Immunol; 1990; 91(4):389-93. PubMed ID: 1976599
[TBL] [Abstract][Full Text] [Related]
12. Beta 2-microglobulin and neopterin: predictive markers for human immunodeficiency virus type 1 infection in children?
Chan MM; Campos JM; Josephs S; Rifai N
J Clin Microbiol; 1990 Oct; 28(10):2215-9. PubMed ID: 2229344
[TBL] [Abstract][Full Text] [Related]
13. [Lymphocyte subpopulations, neopterin, and beta-2-microglobulin: relationship with clinical stage, risk of progression to AIDS and presence of active infection in HIV infection].
Antón F; Labarga P; Pinilla J; Soto MJ; Leoz A; del Cura J; Borque L; Milazzo A
Enferm Infecc Microbiol Clin; 1993; 11(7):373-7. PubMed ID: 8104488
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of serum beta 2-microglobulin in HIV infection.
Krämer A; Goedert JJ; Wachter H; Fuchs D
Lancet; 1992 Aug; 340(8815):371. PubMed ID: 1379663
[No Abstract] [Full Text] [Related]
15. The 90K tumor-associated antigen and clinical progression in human immunodeficiency virus infection.
Iacobelli S; Ullrich A; Tinari N; Ortona L; Tamburrini E; D'Egidio M; Ghinelli F; Sighinolfi L; Piazza M; Chirianni A
J Acquir Immune Defic Syndr Hum Retrovirol; 1995 Dec; 10(4):450-6. PubMed ID: 7583441
[TBL] [Abstract][Full Text] [Related]
16. Immunologic markers of AIDS progression: consistency across five HIV-infected cohorts. Multicohort Analysis Project Workshop. Part I.
AIDS; 1994 Jul; 8(7):911-21. PubMed ID: 7946100
[TBL] [Abstract][Full Text] [Related]
17. Decreased plasma concentrations of HDL cholesterol in HIV-infected individuals are associated with immune activation.
Zangerle R; Sarcletti M; Gallati H; Reibnegger G; Wachter H; Fuchs D
J Acquir Immune Defic Syndr (1988); 1994 Nov; 7(11):1149-56. PubMed ID: 7932082
[TBL] [Abstract][Full Text] [Related]
18. [Prognostic factors in HIV-infected heroin addicts: a multivariate analysis of nonspecific serological factors in the evolution of the infection].
Echániz P; Larrañaga P; Arrizabalaga J; Jiménez JL; Iribarren JA; Cuadrado E
Rev Clin Esp; 1992 May; 190(8):422-6. PubMed ID: 1620946
[TBL] [Abstract][Full Text] [Related]
19. Changes in serum neopterin and serum beta 2-microglobulin in subjects with lung infections.
Carstens J; Andersen PL
Eur Respir J; 1994 Jul; 7(7):1233-8. PubMed ID: 7925900
[TBL] [Abstract][Full Text] [Related]
20. Immunologic marker paths for seroconversion: single determinations of immunoglobulin A and beta 2-microglobulin are not adequate to estimate time of HIV infection. Multicohort Analysis Project Workshop. Part II.
AIDS; 1994 Jul; 8(7):923-33. PubMed ID: 7946101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
